April 20, 2026 — Bracco Imaging has announced a strategic alliance with NYU Langone Health to advance innovation in medical imaging through the signing of a multi-year Master Research Agreement (MRA). By combining resources, scientific capabilities and complementary expertise, the collaboration aims to accelerate the development and optimization of advanced imaging technologies, enhancing clinical insights and contributing to improved patient management.
The partnership will focus on key areas of diagnostic imaging, including magnetic resonance imaging (MRI), photon-counting computed tomography (PCCT), targeted ultrasound, and artificial intelligence-enabled PET/CT and MRI image analysis. Through this collaboration, both parties aim to further support the advancement of precision medicine and enable more informed and timelier clinical decision-making.
The agreement is designed to foster closer interaction between research and clinical practice, facilitating the translation of scientific discoveries into real-world healthcare applications. Joint research activities will leverage NYU Langone Health’s clinical and academic excellence alongside Bracco’s longstanding expertise in contrast imaging and diagnostic solutions.
“The agreement reflects a shared commitment between the Bracco Group and NYU Langone Health to advance research and clinical innovation in medical imaging” said Fulvio Renoldi Bracco, Vice Chairman and CEO of Bracco Imaging. NYU Langone Health is among the world’s most respected leaders in radiology, with a proven history in translational research and an exceptional ability to combine clinical practice, advanced technologies, and academic expertise. By combining our respective strengths, we aim to further enhance diagnostic performance, streamline clinical workflows and ultimately generate meaningful impact for patients and healthcare systems”.
"Diagnostic imaging is advancing at a remarkable pace, and strategic collaborations are essential to progress” said Michael P. Recht, MD., the Louis Marx Professor of Radiology and chair of the Department of Radiology at NYU Grossman School of Medicine. “We are excited to build on NYU Langone Health's legacy of advances and to work with The Bracco Group toward breakthroughs in modalities central to precision medicine in terms of superior diagnostic accuracy and enhanced clinical decision-making”.
Go to www.bracco.com for more information.
July 10, 2026 
